logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

John Radford

University of Manchester and The Christie NHS Foundation Trust
H指数:87
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter’s transformation.

Mosunetuzumab单药治疗在复发/难治性Richter’s transformation患者中是有效的且可耐受的。

Blood Advances
IF7.1
2026-02-090
OAAI
Katharine Louise Lewis; Sarit E Assouline; Ross Baker; Nancy L Bartlett; Dima El-Sharkawi; Pratyush Giri; Matthew Ku; Matthew Matasar; Stephen Schuster; John Radford; Michael C Wei; Shen Yin; Antonia Kwan; Iris To; Vibya Raghavan; Lihua E Budde; Chan Y Cheah
Camidanlumab Tesirine in Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 Study

Camidanlumab Tesirine 在复发或难治性经典型霍奇金淋巴瘤中的应用：一项 II 期研究

Blood Advances
IF7.1
2025-08-190
OAAI
Alex F. Herrera; Stephen M. Ansell; Pier Luigi Zinzani; John Radford; Kami Maddocks; Antonio Pinto; Graham P. Collins; Veronika Bachanova; Nancy L. Bartlett; Isabelle Bence-Bruckler; Mehdi Hamadani; Justin Kline; Jiří Mayer; Kerry J. Savage; Ranjana H. Advani; Paolo F. Caimi; René-Olivier Casasnovas; Tatyana Feldman; Brian Hess; Mariana Bastos-Oreiro
Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial

在LOTIS-2临床试验中接受loncastuximab tesirine治疗的老年和年轻患者的临床结果

BLOOD ADVANCES
IF7.1
2023-12-282
OAAI
Hamadani, Mehdi; Spira, Alexander; Zhou, Xiaolei; Liao, Laura; Chen, Lei; Radford, John; Ai, Weiyun; Solh, Melhem; Ardeshna, Kirit M.; Hess, Brian; Caimi, Paolo F.; Stathis, Anastasios; Carlo-Stella, Carmelo; Alderuccio, Juan Pablo; Kahl, Brad; Wang, Ying; Qin, Yajuan; Xu, Zhiying Cindy; Zinzani, Pier Luigi
Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial

高敏感性心肌肌钙蛋白I指导联合血管紧张素受体阻滞剂和 β 受体阻滞剂预防蒽环类药物心脏毒性的多中心，前瞻性，随机对照试验: 心脏护理试验

CIRCULATION
IF38.6
2023-11-2116
OAAI
Henriksen, Peter A.; Hall, Peter; MacPherson, Iain R.; Joshi, Shruti S.; Singh, Trisha; Maclean, Morag; Lewis, Steff; Rodriguez, Aryelly; Fletcher, Alex; Everett, Russell J.; Stavert, Harriet; Broom, Angus; Eddie, Lois; Primrose, Lorraine; McVicars, Heather; McKay, Pam; Borley, Annabel; Rowntree, Clare; Lord, Simon; Collins, Graham; Radford, John; Guppy, Amy; Williams, Michelle C.; Japp, Alan; Payne, John R.; Newby, David E.; Mills, Nicholas L.; Oikonomidou, Olga; Lang, Ninian N.
PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial

PET/CT生物标志物可对参加LOTIS-2临床试验的复发/难治性弥漫性大b细胞淋巴瘤患者进行风险分层

CLINICAL CANCER RESEARCH
IF10.2
2023-10-194
OA
Alderuccio, Juan Pablo; Reis, Isildinha M.; Hamadani, Mehdi; Nachiappan, Muthiah; Leslom, Salman; Kahl, Brad S.; Ai, Weiyun Z.; Radford, John; Solh, Melhem; Ardeshna, Kirit M.; Hess, Brian T.; Lunning, Matthew A.; Zinzani, Pier Luigi; Stathis, Anastasios; Carlo-Stella, Carmelo; Lossos, Izidore S.; Caimi, Paolo F.; Han, Sunwoo; Yang, Fei; Kuker, Russ A.; Moskowitz, Craig H.
Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase II LOTIS-2 study

Loncastuximab tesirine治疗复发/难治性弥漫大B细胞淋巴瘤：II期LOTIS-2研究的长期疗效与安全性

HAEMATOLOGICA
IF7.9
2023-08-3128
OAAI
Caimi, Paolo F.; Ai, Weiyun Z.; Alderuccio, Juan Pablo; Ardeshna, Kirit M.; Hamadani, Mehdi; Hess, Brian; Kahl, Brad S.; Radford, John; Solh, Melhem; Stathis, Anastasios; Zinzani, Pier Luigi; Wang, Ying; Qin, Yajuan; Wang, Luqiang; Xu, Zhiying Cindy; Stella, Carmelo Carlo-
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network
BLOOD ADVANCES
IF7.1
2023-08-280
OAAI
Hapgood, Greg; Civallero, Monica; Stepanishyna, Yana; Vose, Julie; Cabrera, Monica Elena; Advani, Ranjana H.; Pileri, Stefano A.; Manni, Martina; Horwitz, Steven M.; Foss, Francine M.; Hitz, Felicitas; Radford, John; Dlouhy, Ivan; Chiattone, Carlos; Kim, Won Seog; Skrypets, Tetiana; Nagler, Arnon; Trotman, Judith; Luminari, Stefano; Federico, Massimo
The iR2 regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: a multicentre, non-randomised, open-label phase 2 study

iR2方案 (伊布替尼 + 来那度胺和利妥昔单抗) 治疗复发/难治性DLBCL: 一项多中心、非随机、开放标签的2期研究

ECLINICALMEDICINE
IF10
2023-02-0112
OAAI
Ramchandren, Radhakrishnan; Johnson, Peter; Ghosh, Nilanjan; Ruan, Jia; Ardeshna, Kirit M.; Johnson, Roderick; Verhoef, Gregor; Cunningham, David; de Vos, Sven; Kassam, Shireen; Fayad, Luis; Radford, John; Bailly, Sarah; Offner, Fritz; Morgan, David; Munoz, Javier; Ping, Jerry; Szafer-Glusman, Edith; Eckert, Karl; Neuenburg, Jutta K.; Goy, Andre
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study

复发/难治性滤泡性淋巴瘤的治疗模式和结果: 来自国际学者5研究的结果

HAEMATOLOGICA
IF7.9
2022-10-2022
OAAI
Ghione, Paola; Palomba, Maria Lia; Ghesquieres, Herve; Bobillo, Sabela; Patel, Anik R.; Nahas, Myrna; Kanters, Steve; Deighton, Kevin; Hatswell, Anthony; Ma, Long; Oldfield, Eve H. Limbrick-; Snider, Julia Thornton; Wade, Sally W.; Riberio, Maria Teresa; Radford, John; Beygi, Sara; Gribben, John
Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study

Loncastuximab tesirine治疗复发/难治性高级别b细胞淋巴瘤: 来自LOTIS-2研究的亚组分析

BLOOD ADVANCES
IF7.1
2022-08-161
OAAI
Alderuccio, Juan P.; Ai, Weiyun Z.; Radford, John; Solh, Melhem; Ardeshna, Kirit M.; Lunning, Matthew A.; Hess, Brian T.; Zinzani, Pier L.; Stathis, Anastasios; Carlo-Stella, Carmelo; Hamadani, Mehdi; Kahl, Brad S.; Ungar, David; Kilavuz, Turk; Yu, Eric; Qin, Yajuan; Caimi, Paolo F.
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma

Brentuximab Vedotin在III期或IV期霍奇金淋巴瘤中的总体生存率

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2022-07-28158
OA
Ansell, Stephen M.; Radford, John; Connors, Joseph M.; Dlugosz-Danecka, Monika; Kim, Won-Seog; Gallamini, Andrea; Ramchandren, Radhakrishnan; Friedberg, Jonathan W.; Advani, Ranjana; Hutchings, Martin; Evens, Andrew M.; Smolewski, Piotr; Savage, Kerry J.; Bartlett, Nancy L.; Eom, Hyeon-Seok; Abramson, Jeremy S.; Dong, Cassie; Campana, Frank; Fenton, Keenan; Puhlmann, Markus; Straus, David J.
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity

心脏护理试验的原理和设计: 肌钙蛋白指导的神经激素阻断预防蒽环类药物心脏毒性的随机试验

jacc heart failure
IF8.4
2022-07-015
OA
Henriksen, Peter A.; Hall, Peter; Oikonomidou, Olga; MacPherson, Iain R.; Maclean, Morag; Lewis, Steff; McVicars, Heather; Broom, Angus; Scott, Fiona; McKay, Pam; Borley, Annabel; Rowntree, Clare; Lord, Simon; Collins, Graham; Radford, John; Guppy, Amy; Payne, John R.; Newby, David E.; Mills, Nick L.; Lang, Ninian N.
Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study

Avelumab联合治疗复发/难治性DLBCL: Ib期标枪DLBCL研究的结果

TARGETED ONCOLOGY
IF4
2021-10-2310
OAAI
Hawkes, Eliza A.; Phillips, Tycel; Budde, Lihua Elizabeth; Santoro, Armando; Saba, Nakhle S.; Roncolato, Fernando; Gregory, Gareth P.; Verhoef, Gregor; Offner, Fritz; Quero, Cristina; Radford, John; Giannopoulos, Krzysztof; Stevens, Don; Thall, Aron; Huang, Bo; Laird, A. Douglas; Sandner, Robin; Ansell, Stephen M.
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study

自体EBV特异性T细胞治疗可导致晚期结外NK/T淋巴瘤患者的持续反应: 多中心研究的结果

ANNALS OF HEMATOLOGY
IF2.4
2021-07-2419
PREAI
Kim, Won Seog; Oki, Yasuhiro; Kim, Seok Jin; Yoon, Sang Eun; Ardeshna, Kirit M.; Lin, Yi; Ruan, Jia; Porcu, Pierluigi; Brammer, Jonathan E.; Jacobsen, Eric D.; Yoon, Dok Hyun; Suh, Cheolwon; Suarez, Felipe; Radford, John; Budde, Lihua E.; Kim, Jin Seok; Bachy, Emmanuel; Lee, Hun Ju; Bollard, Catherine M.; Jaccard, Arnaud; Kang, Hye Jin; Inman, Shannon; Murray, Maryann; Combs, Katherin E.; Lee, Daniel Y.; Advani, Ranjana; Gunter, Kurt C.; Rooney, Cliona M.; Heslop, Helen E.
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study

先前未经治疗的晚期经典霍奇金淋巴瘤的老年患者 (年龄 ≥ 60岁): 来自III期ECHELON-1研究的详细分析

HAEMATOLOGICA
IF7.9
2021-06-2440
OAAI
Evens, Andrew M.; Connors, Joseph M.; Younes, Anas; Ansell, Stephen M.; Kim, Won Seog; Radford, John; Feldman, Tatyana; Tuscano, Joseph; Savage, Kerry J.; Oki, Yasuhiro; Grigg, Andrew; Pocock, Christopher; Dlugosz-Danecka, Monika; Fenton, Keenan; Forero-Torres, Andres; Liu, Rachael; Jolin, Hina; Gautam, Ashish; Gallamini, Andrea
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

Brentuximab vedotin联合化疗治疗III期或IV期经典霍奇金淋巴瘤 (ECHELON-1): 一项国际、开放标签、随机、3期试验的5年更新

LANCET HAEMATOLOGY
IF17.7
2021-06-0198
PRE
Straus, David J.; Dlugosz-Danecka, Monika; Connors, Joseph M.; Alekseev, Sergey; Illes, Arpad; Picardi, Marco; Lech-Maranda, Ewa; Feldman, Tatyana; Smolewski, Piotr; Savage, Kerry J.; Bartlett, Nancy L.; Walewski, Jan; Ramchandren, Radhakrishnan; Zinzani, Pier Luigi; Hutchings, Martin; Munoz, Javier; Lee, Hun Ju; Kim, Won Seog; Advani, Ranjana; Ansell, Stephen M.; Younes, Anas; Gallamini, Andrea; Liu, Rachael; Little, Meredith; Fenton, Keenan; Fanale, Michelle; Radford, John

研究方向

暂未获取到该数据
P
Peter Johnson
H 指数:99论文数:1,141被引数:4.0万
K
Kim Linton
H 指数:34论文数:348被引数:5,560
P
Pier Luigi Zinzani
H 指数:117论文数:1,841被引数:6.1万
K
Kirit M. Ardeshna
H 指数:36论文数:242被引数:5,865
D
David Cunningham
H 指数:153论文数:2,060被引数:13.0万
S
Stephen M. Ansell
H 指数:111论文数:1,484被引数:5.1万
M
Mehdi Hamadani
H 指数:68论文数:957被引数:1.9万
R
Ranjana H. Advani
H 指数:100论文数:840被引数:4.7万
J
Joseph M. Connors
H 指数:120论文数:788被引数:9.0万
C
Carmelo Carlo‐Stella
H 指数:50论文数:736被引数:1.4万